Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teleflex (TFX)
:TFX
Holding TFX?
Track your performance easily
TFX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$171.69 - $256.85
Previous CloseN/A
Volume73.33K
Average Volume (3M)471.55K
Market Cap
$8.43B
Enterprise Value$13.22B
Total Cash (Recent Filing)$543.79M
Total Debt (Recent Filing)$850.25M
Price to Earnings (P/E)36.1
Beta1.16
Next Earnings
Feb 20, 2025EPS Estimate
3.86Last Dividend Ex-Date
Nov 15, 2024Dividend Yield0.75%
Share Statistics
EPS (TTM)5.03
Shares Outstanding46,443,733
10 Day Avg. Volume520,978
30 Day Avg. Volume471,553
Standard Deviation0.09
R-Squared0.45
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.79
Price to Cash Flow (P/CF)9.10
P/FCF Ratio10.00
Enterprise Value/Market Cap1.57
Enterprise Value/Revenue4.37
Enterprise Value/Gross Profit8.03
Enterprise Value/Ebitda21.61
Forecast
1Y Price Target
$242.88Price Target Upside33.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Teleflex News
PremiumCompany Announcements
Teleflex Announces Q3 2024 Financial ResultsBulls Say, Bears Say
Bulls Say
Market Share ExpansionChallenges faced by a competitor in the IABP market are anticipated to benefit Teleflex, potentially boosting sales and earnings.
Product Revenue GrowthTeleflex's Barrigel product line is expected to be a significant revenue contributor for years to come.
Strategic AcquisitionThe acquisition would make strategic sense for TFX since the Biotronik products would be complementary to TFX's Interventional business.
Bears Say
AcquisitionsAn agreement may not be reached in the discussions to acquire Biotronik's vascular business.
Customer LossThe company lost an OEM customer which decided to vertically integrate, resulting in a revenue loss of approximately $14 million in the second half of the year.
RevenueManagement lowered its constant currency revenue growth guidance.
---
Ownership Overview
0.30% Insiders
42.60% Mutual Funds
0.23% Other Institutional Investors
29.24% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TFX FAQ
What was Teleflex’s price range in the past 12 months?
Teleflex lowest stock price was $171.69 and its highest was $256.85 in the past 12 months.
What is Teleflex’s market cap?
Teleflex’s market cap is $8.43B.
When is Teleflex’s upcoming earnings report date?
Teleflex’s upcoming earnings report date is Feb 20, 2025 which is in 31 days.
How were Teleflex’s earnings last quarter?
Teleflex released its earnings results on Oct 31, 2024. The company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.392 by $0.098.
Is Teleflex overvalued?
According to Wall Street analysts Teleflex’s price is currently Undervalued.
Does Teleflex pay dividends?
Teleflex pays a Quarterly dividend of $1.36 which represents an annual dividend yield of 0.75%. See more information on Teleflex dividends here
What is Teleflex’s EPS estimate?
Teleflex’s EPS estimate is 3.86.
How many shares outstanding does Teleflex have?
Teleflex has 46,443,733 shares outstanding.
What happened to Teleflex’s price movement after its last earnings report?
Teleflex reported an EPS of $3.49 in its last earnings report, beating expectations of $3.392. Following the earnings report the stock price went down -14.523%.
Which hedge fund is a major shareholder of Teleflex?
Among the largest hedge funds holding Teleflex’s share is Woodline Partners LP. It holds Teleflex’s shares valued at 75M.
---
Teleflex Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$242.88 (33.99% Upside)
$242.88 (33.99% Upside)
Blogger Sentiment
Bullish
TFX Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 13.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 15.6%
Last 30 Days ▼ 15.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.51%
12-Months-Change
Fundamentals
Return on Equity
5.41%
Trailing 12-Months
Asset Growth
-0.10%
Trailing 12-Months
Company Description
Teleflex
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.
---
TFX Company Deck
---
TFX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with several positive highlights, such as revenue growth in key segments and successful acquisition performance, but also highlighted challenges in OEM revenue, UroLift growth, and a higher tax rate. Despite these challenges, the company showed strong cash flow and improved gross margins.Read More>---
TFX Stock 12 Month Forecast
Average Price Target
$242.88
▲(33.99% Upside)
Technical Analysis
Zimmer Biomet Holdings
―
Baxter International
―
Hologic
―
Medtronic
―
Boston Scientific
―
Edwards Lifesciences
―
Best Analysts Covering TFX
1 Year
1 Year Success Rate
5/19 ratings generated profit
1 Year Average Return
-14.54%
reiterated a buy rating 3 months ago
Copying David Turkaly's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -14.54% per trade.
---